Larimar Therapeutics, Inc. (LRMR)
3.85
-0.02
(-0.52%)
USD |
NASDAQ |
Sep 03, 11:25
Larimar Therapeutics Total Assets (Quarterly) : 165.30M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 165.30M |
| March 31, 2026 | 208.51M |
| December 31, 2025 | 146.46M |
| September 30, 2025 | 187.35M |
| June 30, 2025 | 149.99M |
| March 31, 2025 | 170.18M |
| December 31, 2024 | 200.93M |
| September 30, 2024 | 219.02M |
| June 30, 2024 | 237.16M |
| March 31, 2024 | 248.20M |
| December 31, 2023 | 95.94M |
| September 30, 2023 | 103.95M |
| June 30, 2023 | 111.72M |
| March 31, 2023 | 118.91M |
| December 31, 2022 | 126.40M |
| September 30, 2022 | 133.02M |
| June 30, 2022 | 62.85M |
| March 31, 2022 | 71.22M |
| December 31, 2021 | 78.67M |
| September 30, 2021 | 87.94M |
| June 30, 2021 | 80.93M |
| March 31, 2021 | 93.02M |
| December 31, 2020 | 104.69M |
| September 30, 2020 | 113.96M |
| June 30, 2020 | 125.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.70M |
| December 31, 2019 | 5.201M |
| September 30, 2019 | 92.89M |
| June 30, 2019 | 103.88M |
| March 31, 2019 | 110.18M |
| December 31, 2018 | 121.76M |
| September 30, 2018 | 131.94M |
| June 30, 2018 | 79.80M |
| March 31, 2018 | 92.61M |
| December 31, 2017 | 105.51M |
| September 30, 2017 | 96.26M |
| June 30, 2017 | 108.84M |
| March 31, 2017 | 119.37M |
| December 31, 2016 | 131.62M |
| September 30, 2016 | 142.71M |
| June 30, 2016 | 154.83M |
| March 31, 2016 | 170.03M |
| December 31, 2015 | 189.11M |
| September 30, 2015 | 207.45M |
| June 30, 2015 | 222.60M |
| March 31, 2015 | 236.72M |
| December 31, 2014 | 117.52M |
| September 30, 2014 | 129.64M |
| June 30, 2014 | 136.97M |
| March 31, 2014 | 41.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 145.38M |
| Marker Therapeutics, Inc. | 14.59M |
| Rezolute, Inc. | 125.46M |
| Krystal Biotech, Inc. | 1.501B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.92M |
| Shareholders Equity (Quarterly) | 127.38M |
| Debt to Equity Ratio | 0.0389 |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | -0.01% |